Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 2020-05-27 20:07
AFT Pharmaceuticals Donates Almost $110,000 To Health Charities When They Need It Most 2020-05-26 08:46
Nucleus Network commences Novavax' Phase 1/2 COVID-19 vaccine trial in Australia 2020-05-26 08:41
Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China 2020-05-26 07:30
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks 2020-05-25 08:18
Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport 2020-05-22 13:00
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio 2020-05-22 07:11
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme 2020-05-21 20:00
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2) 2020-05-21 14:00
Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' 2020-05-21 10:03
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology 2020-05-21 08:58
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction 2020-05-21 04:45
China Biologic Reports Financial Results for the First Quarter of 2020 2020-05-21 04:30
Macrogen Approved for Export of its COVID-19 Test Kit 2020-05-20 21:00
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities 2020-05-20 19:34
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models 2020-05-20 19:00
I-Mab Expands Global Presence with New Hong Kong Office 2020-05-20 16:00
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification 2020-05-20 07:11
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia 2020-05-19 19:00
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections 2020-05-19 09:45
1 294 295 296 297 298 412